ES2193233T3 - Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica. - Google Patents

Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.

Info

Publication number
ES2193233T3
ES2193233T3 ES96901940T ES96901940T ES2193233T3 ES 2193233 T3 ES2193233 T3 ES 2193233T3 ES 96901940 T ES96901940 T ES 96901940T ES 96901940 T ES96901940 T ES 96901940T ES 2193233 T3 ES2193233 T3 ES 2193233T3
Authority
ES
Spain
Prior art keywords
heart failure
phelodipine
amiodipine
ischemical
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901940T
Other languages
English (en)
Inventor
Anne B Cropp
Allen R Kraska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2193233T3 publication Critical patent/ES2193233T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS QUE CONTIENEN (1) AMLODIPINA, UNA SAL FARMACEUTICAMENTE ACEPTABLE DE AMLODIPINA, O FELODIPINA; (2) UN INHIBIDOR DE ACE Y, OPCIONALMENTE, (3) UN DIURETICO; Y/O (4) DIGOXINA. EL USO DE LAS COMPOSICIONES RESULTA EN UNA MORBOSIDAD Y/O MORTALIDAD MEJORADA PARA EL TRATAMIENTO DEL COLAPSO CONGESTIVO. TAMBIEN, METODOS PARA EL TRATAMIENTO DEL COLAPSO CONGESTIVO DE UN MAMIFERO, ESPECIALMENTE UN SER HUMANO, MEDIANTE AL COADMINISTRACION DE (1) AMLODIPINA, UNA SAL FARMACEUTICAMENTE ACEPTABLE DE AMLODIPINA, O FELODIPINA; (2) UN INHIBIDOR DE ACE Y, OPCIONALMENTE, (3) UN DIURETICO Y/O (4) DIGOXINA.
ES96901940T 1995-03-16 1996-02-26 Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica. Expired - Lifetime ES2193233T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40510895A 1995-03-16 1995-03-16

Publications (1)

Publication Number Publication Date
ES2193233T3 true ES2193233T3 (es) 2003-11-01

Family

ID=23602311

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901940T Expired - Lifetime ES2193233T3 (es) 1995-03-16 1996-02-26 Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.

Country Status (12)

Country Link
US (1) US6245787B1 (es)
EP (1) EP0804229B1 (es)
JP (2) JPH11500140A (es)
AT (1) ATE235251T1 (es)
CA (1) CA2215234C (es)
DE (1) DE69626958T2 (es)
DK (1) DK0804229T3 (es)
ES (1) ES2193233T3 (es)
FI (1) FI973691A (es)
MX (1) MX9706957A (es)
PT (1) PT804229E (es)
WO (1) WO1996028185A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
EP1695716A2 (en) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medicinal compositions containing diuretics and insulin sensitizers
TW200306799A (en) * 2002-05-17 2003-12-01 Novartis Ag Combination of organic compounds
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
HUP0401170A2 (en) 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
US20070142473A1 (en) * 2005-12-15 2007-06-21 Lawrence Solomon Dosage forms and methods using ethacrynic acid
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
SI2538924T1 (sl) 2010-02-24 2014-09-30 Sanofi-Aventis Deutschland Gmbh Trdne farmacevtske formulacije ramiprila in amlodipin bezilata in njihova priprava
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
US20150272930A1 (en) * 2014-04-01 2015-10-01 AILEX Pharmaceuticals PVT. LTD. Fixed Dosage Formulations of Angiotensin Converting Enzyme (ACE) inhibitor and the Diuretic Chlorthalidone
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE3633496A1 (de) 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
NZ242724A (en) 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
EP0795327A1 (en) 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
MX9706957A (es) 1997-11-29
CA2215234A1 (en) 1996-09-19
EP0804229B1 (en) 2003-03-26
CA2215234C (en) 2001-12-11
FI973691A0 (fi) 1997-09-15
EP0804229A2 (en) 1997-11-05
JPH11500140A (ja) 1999-01-06
ATE235251T1 (de) 2003-04-15
PT804229E (pt) 2003-06-30
JP2003286170A (ja) 2003-10-07
DK0804229T3 (da) 2003-04-22
FI973691A (fi) 1997-09-15
WO1996028185A2 (en) 1996-09-19
DE69626958D1 (de) 2003-04-30
US6245787B1 (en) 2001-06-12
DE69626958T2 (de) 2004-03-18
WO1996028185A3 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
EE200000378A (et) Adamantaani derivaadid
DK0479903T3 (da) Substituerede imidazoler og deres anvendelse som angiotensin II hæmmere
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
SE9503143D0 (sv) New preparation
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
AU2855399A (en) Vascularization inhibitors
NO934706L (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
DE69814394D1 (de) Verwendung von levobupivacain
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
BR9100221A (pt) Composto;metodo para o tratamento de hipertensao,falha cardiaca congestiva ou glaucoma em um mamifero;e composicao farmaceutica
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
IS4174A (is) Ný notkun á lyfjafræðilega viðurkenndu salti
ES2191206T3 (es) Nueva utilizacion de la creatina.
DE68906245D1 (de) Therapeutisches mittel gegen aids.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
SE9602262D0 (sv) New use of derivatives of cystine
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.